US Patent 11242361 Proteasome activity enhancing compounds
Patent 11242361 was granted and assigned to Proteostasis Therapeutics on February, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 15, 2020
0
Date of Patent
February 8, 2022
0
Patent Applicant
Patent Application Number
16902019
0
Patent Citations Received
Patent Inventor Names
Benito Munoz
0
Matthew Cullen
0
Megan Foley
0
Sheila Hauck
0
Bolin Geng
0
Bradley Tait
0
Cecilia M. Bastos
0
Markus Haeberlein
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11242361 Proteasome activity enhancing compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
